Black Creek Investment Management’s GSK GSK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | – | Sell |
-7,366,879
| Closed | -$401M | – | 39 |
|
|
2022
Q1 | $401M | Sell |
7,366,879
-932,275
| -11% | -$50.8M | 11.3% | 4 |
|
|
2021
Q4 | $457M | Buy |
8,299,154
+35,675
| +0.4% | +$1.97M | 12.2% | 2 |
|
|
2021
Q3 | $395M | Buy |
8,263,479
+993,983
| +14% | +$47.5M | 11.46% | 3 |
|
|
2021
Q2 | $362M | Buy |
7,269,496
+334,697
| +5% | +$16.7M | 11.19% | 3 |
|
|
2021
Q1 | $309M | Buy |
6,934,799
+980,350
| +16% | +$43.7M | 10.25% | 4 |
|
|
2020
Q4 | $274M | Buy |
5,954,449
+765,748
| +15% | +$35.2M | 8.54% | 5 |
|
|
2020
Q3 | $244M | Buy |
5,188,701
+551,748
| +12% | +$26M | 9.28% | 4 |
|
|
2020
Q2 | $236M | Sell |
4,636,953
-320,437
| -6% | -$16.3M | 9.55% | 4 |
|
|
2020
Q1 | $235M | Sell |
4,957,390
-849,190
| -15% | -$40.2M | 9.43% | 3 |
|
|
2019
Q4 | $341M | Sell |
5,806,580
-82,467
| -1% | -$4.84M | 10.71% | 1 |
|
|
2019
Q3 | $314M | Sell |
5,889,047
-472,254
| -7% | -$25.2M | 10.99% | 1 |
|
|
2019
Q2 | $318M | Buy |
6,361,301
+10,256
| +0.2% | +$513K | 10.49% | 1 |
|
|
2019
Q1 | $332M | Buy |
6,351,045
+306,522
| +5% | +$16M | 11.32% | 1 |
|
|
2018
Q4 | $289M | Buy |
6,044,523
+927,560
| +18% | +$44.3M | 10.45% | 1 |
|
|
2018
Q3 | $257M | Buy |
5,116,963
+13,072
| +0.3% | +$656K | 7.82% | 6 |
|
|
2018
Q2 | $257M | Buy |
5,103,891
+207,938
| +4% | +$10.5M | 7.84% | 6 |
|
|
2018
Q1 | $239M | Buy |
+4,895,953
| New | +$239M | 7.82% | 6 |
|